Please check your internet connection and try again.
## Lorazepam
### Overview
Lorazepam is a benzodiazepine with sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA(A) receptor.
### Primary Indications
* **Anxiety Disorders:** Short-term management of anxiety symptoms.
* **Insomnia:** Short-term management of insomnia characterized by difficulty falling asleep or staying asleep.
* **Status Epilepticus:** First-line treatment for established status epilepticus.
* **Preanesthetic Medication:** To reduce anxiety and provide sedation prior to surgical procedures.
### Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed. May increase to 4 mg/day in divided doses.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV or IM. If seizures persist, a second dose of 4 mg may be administered after 10 to 15 minutes. Maximum recommended initial dose: 4 mg.
* **Preanesthetic:** 2 mg to 4 mg IM given 2 hours before surgery.
### Pediatric Dosing
Dosing in pediatric patients is not well-established and should be individualized based on age, weight, and clinical response. Extreme caution is advised due to potential for paradoxical reactions and respiratory depression.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May be repeated once after 10-15 minutes.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** Use with caution; dose reduction may be necessary, especially in severe impairment.
* **Elderly:** Lower doses are generally recommended due to increased sensitivity and risk of side effects. Start with 0.5 mg to 1 mg orally per day.
### Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
### Adverse Effects
* **Common:** Drowsiness, dizziness, weakness, unsteadiness, fatigue, impaired coordination.
* **Serious:** Paradoxical reactions (e.g., excitation, aggression), anterograde amnesia, respiratory depression, severe hypotension (especially with IV administration), dependence and withdrawal symptoms upon abrupt discontinuation.
### Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam plasma concentrations.
### Monitoring
* **Clinical Status:** Assess for improvement in anxiety, sleep, or seizure control.
* **Respiratory Rate and Depth:** Especially with parenteral administration or in combination with other respiratory depressants.
* **Mental Status:** Monitor for sedation, confusion, and paradoxical reactions.
* **Signs of Dependence/Withdrawal:** Observe for symptoms if dose reduction or discontinuation is planned.
### Clinical Pearls
* Lorazepam has a moderate half-life, making it suitable for both acute and short-term maintenance therapy.
* Intramuscular absorption is generally reliable. Intravenous administration should be slow to minimize respiratory depression.
* Avoid abrupt discontinuation; taper dose gradually to minimize withdrawal symptoms.
* Use the lowest effective dose for the shortest duration necessary.
* Due to its high potency and potential for abuse, lorazepam should be prescribed cautiously.
***
*Disclaimer: This information is intended for healthcare professionals and does not replace clinical judgment. Always consult the most current prescribing information and relevant guidelines for complete details before prescribing or administering any medication.*
